A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)
Crossref DOI link: https://doi.org/10.1007/s00280-015-2681-3
Published Online: 2015-02-04
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Infante, Jeffrey R.
Ramanathan, Ramesh K.
George, Daniel
Tan, Eugene
Quinlan, Michelle
Liu, Angela
Scott, Jeffrey W.
Sharma, Sunil
Text and Data Mining valid from 2015-02-04